Table 5.
Overall survival of patients with high tumor CXCR6 expression.
| Type of Cancer | Number of Patients | Overall Survival for An Increased Amount of CXCR6 | Comments | References |
|---|---|---|---|---|
| Bladder cancer | 155 | -- | [177] | |
| Cervical cancer | 60 | ↓ | [125] | |
| Ewing sarcoma family tumor | 61 | ↓ | [126] | |
| Gastric cancer | 352 | ↓ | [102] | |
| Gastrointestinal stromal tumor | 43 | ↓ | [107] | |
| Hepatocellular carcinoma | 240 | ↓ | p = 0.064 | [32] |
| Lung cancer (non-small cell lung cancer) | 58 | -- | [179] | |
| Ovarian carcinoma | 56 | -- | [128] | |
| Ovarian cancer | 268 | -- | [180] | |
| Pancreatic ductal adenocarcinoma | 112 | ↑ | Early stage of pancreatic ductal adenocarcinoma cases, from TCGA dataset | [184] |
| Prostate cancer | 476 | ↓ | [108] | |
| Renal cell carcinoma (clear cell renal cell carcinoma) | 239 | ↓ | [186] | |
| Renal cell carcinoma | 104 | -- | [14] | |
| Thyroid cancer (papillary thyroid cancer) | 136 | -- | [114] |
↑-better overall survival; ↓-poorer overall survival; --–no correlation.